Paulo

Elixir Medical To Announce Data from Three Platforms Designed to Transform Cardiovascular Disease Treatment at EuroPCR 2024, Including Two Late-Breakers

Retrieved on: 
Tuesday, April 30, 2024
Research, Medical Devices, Clinical Trials, Health Technology, Cardiology, Biotechnology, Health, General Health, Science, Elixir, Hospital, Coronary artery disease, Safety, PINNACLE, Catheterization laboratory, MD, Trial of the century, Doctor of Philosophy, PCI, TRX, OCT, CAD, Medicine, DES, Standard of care, Paulo, RCT, Plaque, MACE, Skåne University Hospital, Catheter, Pharmaceutical industry

“There remains a large unmet need for transformative technology in cardiovascular intervention to address limitations of coronary artery disease (CAD) treatments such as maintaining the established artery flow lumen, restoring vessel hemodynamic modulation, and stabilizing or regressing plaque to deliver durable and incremental clinical benefit.

Key Points: 
  • “There remains a large unmet need for transformative technology in cardiovascular intervention to address limitations of coronary artery disease (CAD) treatments such as maintaining the established artery flow lumen, restoring vessel hemodynamic modulation, and stabilizing or regressing plaque to deliver durable and incremental clinical benefit.
  • In the absence of restoring artery function, today we see 20% MACE within 5 years1 and 50% by 10 years2 after PCI attributable to non-plateauing annual adverse events with DES,”3 said Motasim Sirhan, CEO of Elixir Medical.
  • Featured as an Innovation Session presentation, the clinical results are intended to demonstrate safety and efficacy of Elixir’s lithotripsy technology designed to simplify treatment of a broad range of complex calcified lesions while advancing safety and efficacy of calcium modification.
  • Additionally, Elixir Medical will share late-breaking 12-month outcomes of its TRx site-specific antithrombotic therapeutic from the DESyne BDS Plus RCT, a prospective, multicenter, single-blind study evaluating the safety, effectiveness, and performance of the world’s first triple-drug site-specific antithrombotic therapy (TRx) on a DES compared to DESyne X2 Drug-Eluting Coronary Stent System in the treatment of de novo native coronary artery lesions.

I Squared Appoints Jonathan Popper as Fund Partner and Head of Asset Management and Value Creation for the Americas

Retrieved on: 
Thursday, April 11, 2024
Banking, Asset Management, Professional Services, Finance, University, Strategic management, Investment, Capital, Portfolio, Morgan Stanley, Mergers and acquisitions, Environment, Partner (business rank), Senior, Dartmouth College, CFA, MBA, Square, Paulo, Management

I Squared Capital, a leading independent global infrastructure investment manager, today announced that Jonathan Popper will be joining the firm as Fund Partner and Head of Asset Management and Value Creation for the Americas.

Key Points: 
  • I Squared Capital, a leading independent global infrastructure investment manager, today announced that Jonathan Popper will be joining the firm as Fund Partner and Head of Asset Management and Value Creation for the Americas.
  • Prior to Temasek, Jon was with Morgan Stanley where he served as Managing Director and Head of Southeast Asia M&A.
  • Commenting on the appointment, Gautam Bhandari, Chief Investment Officer and Managing Partner, I Squared, said: “I’m delighted to welcome Jon to I Squared.
  • In March, I Squared announced the appointment of Yves Meyer Bulow as Fund Partner and Office head for the firm’s new Munich office.

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

Retrieved on: 
Thursday, April 25, 2024
Public, WHO, Safety, World Health Organization, City, Trial of the century, Half-life, Dengue virus, Polymer, Viral load, Patient, Fever Dream, Infection, Death, COVID-19, Paulo, Vaccine

Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval

Key Points: 
  • Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval
    SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in Brazil, which has the highest number of dengue cases and deaths in the world.
  • Hyundai Bioscience outlined two main reasons for choosing Brazil as its Dengue clinical trial regions:
    Firstly, Brazil has been the most affected country by the Dengue virus.
  • Hyundai Bioscience plans to conduct a basket-type clinical trial in Brazil (confirmatory clinical study for Dengue and exploratory clinical study for other mosquito-borne viral infections).
  • "The success of Dengue clinical study on our Niclosamide-based antiviral could lead to its emergency use authorization not only in Brazil but also in other countries.

EQS-News: Direct Sao Paulo to Gauteng flights opens a myriad of opportunities for Brazilian travelers

Retrieved on: 
Wednesday, April 10, 2024
Rhinoceros, Monday, Culture, Taste, São Paulo/Guarulhos International Airport, Big Five, Fungus, River, Tuesday, Cave, City, Restaurant, Fern, Cape Town International Airport, SAA, Aircraft, Tree, Animal, Paulo, Movement, Cradle, Flower

Since the launch, the flights have a more than 60% load factor which is expected to grow” said Sthembiso Dlamini GTA’s CEO.

Key Points: 
  • Since the launch, the flights have a more than 60% load factor which is expected to grow” said Sthembiso Dlamini GTA’s CEO.
  • Within 9-10 hrs Brazilian travellers can immerse themselves in the rich tapestry of experiences that Gauteng offers – from its vibrant urban lifestyle to its stunning natural landscapes.
  • It is an invitation to explore the #GPLifestyle -  a unique blend of adventure, culture, and cuisine that the province is renowned for.
  • Gauteng is known for top restaurants that provide a vast selection of cuisine from across the African continent and the globe.

FTI Consulting Adds Former Mexican Government Energy Official to Growing Litigation & Disputes Resolution Practice

Retrieved on: 
Wednesday, March 27, 2024
Growth, FCN, NERA, International arbitration, Associate, Strategic planning, FTI Consulting, Brattle Group, FTI, Senior, Economy, Lawsuit, Economic consulting, NERA Economic Consulting, Paulo, Economics

WASHINGTON, March 27, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Veronica Irastorza as a Senior Managing Director in the Litigation & Disputes Resolution practice within the firm’s Economic Consulting segment.

Key Points: 
  • WASHINGTON, March 27, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Veronica Irastorza as a Senior Managing Director in the Litigation & Disputes Resolution practice within the firm’s Economic Consulting segment.
  • Ms. Irastorza joins FTI Consulting with more than 20 years of experience supporting clients with issues related to competition, regulation, economics of contracts, markets, damages, valuations, disputes and arbitrations, primarily in the energy sector.
  • “As energy investment continues to grow in Latin America, political and regulatory changes in an industry that is transitioning worldwide are resulting in a growing number of disputes,” said Dr. Jose Alberro , a Senior Managing Director in the Litigation & Dispute Resolution practice and Head of International Arbitration for Latin America at FTI Consulting.
  • The team joins a growing practice of experts across Canada, the United States and Latin America led by Dr. Randal Heeb .

Maniv Announces Third Early-stage Venture Fund of $140m to Accelerate the Decarbonization and Digitization of Global Transportation

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Other Natural Resources, Logistics, Supply Chain Management, Mining, Minerals, Sustainability, Other Automotive, Public Policy, Government, Natural Resources, Other Manufacturing, Fleet Management, Other Defense, Other Energy, Automotive, Manufacturing, Alternative Energy, Energy, Other Transport, Trucking, Transport, Other Technology, Fintech, Defense, Environment, Food, Beverage, Technology, Retail, Business, Other Professional Services, State, Local, Finance, EV, Shell, Bipi Island, GHG, Jaguar Land Rover, General partnership, Circular, Ferrovial, WEX, AI, Insurance, Kolors, Private sector, Enterprise mobility management, BNP Paribas, Investment, Plastic, Atmosphere, Valeo, Movement, Paulo, Toyota, ITT Inc., Silicon, RCI Banque, Renewable energy

Investing since 2016, Maniv was among the first institutional investors to articulate a global, early-stage investment strategy focused on the intersection between mobility, transportation and energy.

Key Points: 
  • Investing since 2016, Maniv was among the first institutional investors to articulate a global, early-stage investment strategy focused on the intersection between mobility, transportation and energy.
  • Simultaneously, the market-driven decarbonization of transportation – representing as much as one quarter of global GHG emissions – is at an inflection point.
  • Maniv’s third fund is backed by institutional capital, high-net-worth individuals, and a consortium of industry leaders at the forefront of the transportation sector.
  • “Our third fund builds on two decades in the trenches of the global mobility ecosystem,” said Michael Granoff, the firm’s Managing Partner.

Argon & Co Expands Its Presence Into Ireland

Retrieved on: 
Thursday, April 4, 2024
Consulting, Business, Logistics, Supply Chain Management, Professional Services, Transport, Partner, Transformation, Paulo, Management

This move represents another step in Argon & Co’s expansion strategy, building on its existing global strategy and transformation capability and enhancing its expertise and scale.

Key Points: 
  • This move represents another step in Argon & Co’s expansion strategy, building on its existing global strategy and transformation capability and enhancing its expertise and scale.
  • Conor Duggan, co-founder of Pebble said, “As Ireland’s leading specialist in Business Design and Transformation, Pebble has consistently demonstrated the value of great business design for our clients.
  • Jean-François Laget, the Group Managing Director of Argon & Co, commented, “We look forward to expanding our footprint and developing a strong presence in Ireland.
  • Argon & Co has offices in Paris, London, Abu Dhabi, Amsterdam, Atlanta, Auckland, Chicago, Dublin, Dusseldorf, Hong Kong, Lausanne, Melbourne, Mumbai, Riyadh, São Paulo, Singapore and Sydney.

Crédit Agricole CIB Appoints Giliane Coeurderoy Senior Country Officer for Brazil

Retrieved on: 
Monday, April 1, 2024
Banking, Professional Services, Finance, Administration, Partnership, Acquisition, HSBC, Paulo, Management

Crédit Agricole CIB today announced the appointment of Giliane Coeurderoy as Senior Country Officer for Brazil.

Key Points: 
  • Crédit Agricole CIB today announced the appointment of Giliane Coeurderoy as Senior Country Officer for Brazil.
  • She will report to Stéphane Ducroizet, Senior Regional Officer for the Americas
    “We are very pleased to have someone of Giliane’s stature within Crédit Agricole, who brings her extensive experience in Brazil, join as our Senior Country Officer to steer our operations there.
  • Giliane Coeurderoy joined Crédit Agricole CIB in 2010, serving most recently as Deputy CEO of Crédit Agricole Italia, in charge of Risk and Compliance.
  • Starting in 2013, Giliane Coeurderoy served as Chief Risk Officer for Crédit Agricole CIB Brazil.

Lucas Oil Premium Motor Oils to Hit South American Markets Through VT Batteries

Retrieved on: 
Thursday, April 4, 2024
Health, Partnership, Motorcycle, Light, Commercial, Senior, Lubricant, Paulo, Drug

The deal will bring Lucas Oil's premium motor oil products to new South American markets, including Argentina, Brazil, Chile, Columbia, Ecuador, Peru and Uruguay, marking an important milestone in the company's global expansion efforts.

Key Points: 
  • The deal will bring Lucas Oil's premium motor oil products to new South American markets, including Argentina, Brazil, Chile, Columbia, Ecuador, Peru and Uruguay, marking an important milestone in the company's global expansion efforts.
  • Under this exclusive agreement, VT Batteries will utilize its extensive network to deliver Lucas Oil's premium range of motor oils to a diverse customer base across the continent.
  • "We are very pleased to partner with VT Batteries to distribute our high-performance lubricants in South America," said Shane Burns, Senior Vice President of Global Sales for Lucas Oil.
  • "We are delighted to partner with Lucas Oil as their exclusive motor oil distributor," said Jose Miguel Alvarez, Commercial Director of VT Batteries.

Laureate Education to Participate at Upcoming Conferences in April

Retrieved on: 
Tuesday, April 2, 2024
Jefferies, American Summit, Morgan Stanley, Laureate Education, Conference, Paulo

Additionally, Eilif Serck-Hanssen, President and CEO of the Company, will deliver a presentation with analysts and investors at the Morgan Stanley Brazil Education Corporate Access Day, taking place on April 16, 2024 at Morgan Stanley offices in São Paulo.

Key Points: 
  • Additionally, Eilif Serck-Hanssen, President and CEO of the Company, will deliver a presentation with analysts and investors at the Morgan Stanley Brazil Education Corporate Access Day, taking place on April 16, 2024 at Morgan Stanley offices in São Paulo.
  • The presentation is scheduled to begin at approximately 11:00 AM EST.
  • Conference participation is by invitation only and registration is mandatory.
  • For more information on the conferences or to schedule a one-on-one or small group meeting with the Company's management, please contact a Jefferies or Morgan Stanley representative.